Optimizing Biosimilar Implementation: A Framework for Access, Adoption, and Sustainability
home / k-cast / optimizing-biosimilar-implementation-a-framework-for-access-adoption-and-sustainability
Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, shares comprehensive insights on institutional approaches to biosimilar adoption, covering evaluation criteria, operational challenges, stakeholder management, safety protocols, payer dynamics, and future strategic considerations for successful implementation across health care settings.
EP. 1: One Institution’s Evidence-Based Approach to Adopting Biosimilars
February 1st 2025A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process that examines clinical data, safety profiles, and cost implications while prioritizing operational efficiency, patient access, and seamless transitions between reference products and biosimilars.
Watch
